Although the results of studies investigating the roles of GLP-1 and GIP in pregnancy therefore appear quite variable, the strength of effects on insulin secretion are so strong outside of pregnancy that it has been suggested that drugs that prolong the half-life of circulating incretins may be suitable treatments for gestational diabetes [17]. The gene discussed is GLP1R; the disease is gestational diabetes.